Also Included In: Lung Cancer; Colorectal Cancer
Article Date: 31 Aug 2012 - 2:00 PDT
Current ratings for:
New Cancer Drug Efficiently Targets Breast, Lung And Colon Cancer; Clinical Trials Could Start Within 2 Years
| Patient / Public: |  | |
| Healthcare Prof: |  | 5 (1 votes) |
Legend has it that Ralph Waldo Emerson once said, "Build a better mousetrap, and the world will beat a path to your door." University of Missouri researchers are doing just that, but instead of building mousetraps, the scientists are targeting cancer drugs. In a new study, MU medicinal chemists have taken an existing drug that is being developed for use in fighting certain types of cancer, added a special structure to it, and created a more potent, efficient weapon against cancer.
"Over the past decade, we have seen an increasing interest in using carboranes in drug design," said Mark W. Lee Jr., assistant professor of chemistry in College of Arts and Science. "Carboranes are clusters of three elements - boron, carbon and hydrogen. Carboranes don't fight cancer directly, but they aid in the ability of a drug to bind more tightly to its target, creating a more potent mechanism for destroying the cancer cells."
In the study, Lee and his research team used carboranes to build new drugs designed to shut off a cancer cell's energy production, which is vital for the cell's survival. All cells produce energy through complex, multi-step processes. The key to an effective drug is targeting the process that cancer cells depend on more than healthy cells. By increasing the binding strength of a drug, a smaller dose is required, minimizing side effects and increasing the effectiveness of the therapy. With carboranes, Lee found that the drug is able to bind 10 times more powerfully.
"The reason why these drugs bind stronger to their target is because carboranes exploit a unique and very strong form of hydrogen bonding, the strongest form of interactions for drugs," Lee said.
Lee said that this discovery also will lead to further uses for the drug.
"Too often, after radiation or chemotherapy, cancer cells repair themselves and reinvade the body," Lee said. "This drug not only selectively shuts off the energy production for the cancer cells, but it also inhibits the processes that allow those cancer cells to repair themselves. When we tested our carborane-based drugs, we found that they were unimaginably potent. So far, we have tested this on breast, lung and colon cancer, all with exceptional results."
According to Lee, this is the first study to show systematically how carboranes can improve the activity of a drug. Lee believes this discovery will open additional possibilities of improving drugs that are used to treat other diseases, not just cancer.
"The end result is that these new drugs could be many thousands of times more potent than the drugs that are used in the clinics today," Lee said.
While it will be several years before the new drug would be available on the market, Lee said that clinical trials could begin within the next two years. Additionally, further testing on other types of cancer is underway.
Visit our breast cancer section for the latest news on this subject.
University of Missouri-Columbia
MLA
n.p. "New Cancer Drug Efficiently Targets Breast, Lung And Colon Cancer; Clinical Trials Could Start Within 2 Years." Medical News Today. MediLexicon, Intl., 31 Aug. 2012. Web.
31 Aug. 2012. <http://www.medicalnewstoday.com/releases/249689.php>
APA
http://www.medicalnewstoday.com/releases/249689.php.
Please note: If no author information is provided, the source is cited instead.
'New Cancer Drug Efficiently Targets Breast, Lung And Colon Cancer; Clinical Trials Could Start Within 2 Years'
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
